JPS59225122A - 悪液質治療改善剤 - Google Patents

悪液質治療改善剤

Info

Publication number
JPS59225122A
JPS59225122A JP58089290A JP8929083A JPS59225122A JP S59225122 A JPS59225122 A JP S59225122A JP 58089290 A JP58089290 A JP 58089290A JP 8929083 A JP8929083 A JP 8929083A JP S59225122 A JPS59225122 A JP S59225122A
Authority
JP
Japan
Prior art keywords
cachexia
patient
pronase
granules
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP58089290A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0376294B2 (enrdf_load_stackoverflow
Inventor
Shigemi Fujisaki
藤崎　茂巳
Takashi Fujisaki
藤崎　隆司
Junichi Yoshida
淳一 吉田
Takahiro Fujisaki
藤崎　恭大
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kaken Pharmaceutical Co Ltd
Original Assignee
Kaken Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kaken Pharmaceutical Co Ltd filed Critical Kaken Pharmaceutical Co Ltd
Priority to JP58089290A priority Critical patent/JPS59225122A/ja
Publication of JPS59225122A publication Critical patent/JPS59225122A/ja
Publication of JPH0376294B2 publication Critical patent/JPH0376294B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP58089290A 1983-05-23 1983-05-23 悪液質治療改善剤 Granted JPS59225122A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP58089290A JPS59225122A (ja) 1983-05-23 1983-05-23 悪液質治療改善剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58089290A JPS59225122A (ja) 1983-05-23 1983-05-23 悪液質治療改善剤

Publications (2)

Publication Number Publication Date
JPS59225122A true JPS59225122A (ja) 1984-12-18
JPH0376294B2 JPH0376294B2 (enrdf_load_stackoverflow) 1991-12-05

Family

ID=13966559

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58089290A Granted JPS59225122A (ja) 1983-05-23 1983-05-23 悪液質治療改善剤

Country Status (1)

Country Link
JP (1) JPS59225122A (enrdf_load_stackoverflow)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6261926A (ja) * 1985-09-13 1987-03-18 Hiroshi Maeda 制癌剤
FR2646605A1 (fr) * 1989-05-08 1990-11-09 Shigemi Fujisaki Activateur de neurones endommages, servant a la prevention et au traitement de maladies
WO1996000082A1 (en) * 1994-06-24 1996-01-04 Cortecs Limited Medical use of bromelain
US7833963B2 (en) 1997-02-25 2010-11-16 Sarantis Pty Ltd Component of bromelain

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6261926A (ja) * 1985-09-13 1987-03-18 Hiroshi Maeda 制癌剤
FR2646605A1 (fr) * 1989-05-08 1990-11-09 Shigemi Fujisaki Activateur de neurones endommages, servant a la prevention et au traitement de maladies
DE3941324A1 (de) * 1989-05-08 1990-11-15 Shigemi Fujisaki Aktivator fuer verletzte neurozyten zur verhuetung und behandlung von krankheiten
DE3941324C2 (enrdf_load_stackoverflow) * 1989-05-08 1992-06-25 Fujisaki, Shigemi, Nishinomiya, Hyogo, Jp
DE3943649C2 (enrdf_load_stackoverflow) * 1989-05-08 1992-10-29 Fujisaki, Shigemi, Nishinomiya, Hyogo, Jp
WO1996000082A1 (en) * 1994-06-24 1996-01-04 Cortecs Limited Medical use of bromelain
US7833963B2 (en) 1997-02-25 2010-11-16 Sarantis Pty Ltd Component of bromelain
US9663777B2 (en) 1997-02-25 2017-05-30 Sarantis Pty Ltd Component of bromelain

Also Published As

Publication number Publication date
JPH0376294B2 (enrdf_load_stackoverflow) 1991-12-05

Similar Documents

Publication Publication Date Title
Gracon et al. Safety of tacrine: clinical trials, treatment IND, and postmarketing experience
JPH0133085B2 (enrdf_load_stackoverflow)
Rämö et al. Self-administration of enzyme substitution in the treatment of exocrine pancreatic insufficiency
US5858998A (en) Budesonide alone or in combination with ursodeoxycholic acid in the therapy of cholestatic liver diseases
Cuttner Splenectomy, steroids, and dextran 70 in thrombotic thrombocytopenic purpura
Winkelmann et al. Response of nodular non-X histiocytosis to vinblastine
JPS59225122A (ja) 悪液質治療改善剤
JPS61293927A (ja) 肝臓疾患予防治療剤
WO2016101324A1 (zh) 含有酶的天然组合物及其在制药中的应用
WO2006043153A2 (en) Use of zinc and copper chelators for the treatment of viral diseases
CN103055164B (zh) 一种治疗单纯舒张期高血压的中药组合物
Lepore Whipple's intestinal lipodystrophy
Glass Hematopoietic activity of glandular mucoprotein from human gastric juice
Sho et al. Orally administered Kampo medicine, Juzen-taiho-to, ameliorates anemia during interferon plus ribavirin therapy in patients with chronic hepatitis C
JPS58189122A (ja) 高脂血症予防治療剤
Sakarcan et al. Antibiotic-induced recurring interstitial nephritis
Hirsh Reversal of the anticoagulant effects of warfarin by vitamin K1
Leach et al. Vaginal manipulation and anaerobic breast abscesses
Ascher et al. Indinavir sulfate renal toxicity in a pediatric hemophiliac with HIV infection
Blanco et al. Safe use of ursodeoxycholic acid in the treatment of dyspeptic symptoms in patients with chronic active hepatitis: a double-blind controlled trial
US20230193228A1 (en) Lipase formulations and methods thereof
JPS5938204B2 (ja) 再生不良性貧血治療剤
Moshal Nutrizym as a pancreatic enzyme replacement
McDougall et al. Lepromatous leprosy presenting with swelling of the legs
Kalay-Yildizhan et al. Ulcerative IgA vasculitis in the setting of warfarin therapy